FDA Limits Use of J&J COVID Vaccine Over Blood Clot Risk
We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global community, the FDAs Peter Marks said.
United States Peter Marks Janssen Johnson Advisory Committee On Immunization Practices Biologics Evaluation Immunization Practices
Source: medscape.com